During the past decade, Affiliated Hospital of Guilin Medical University conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 1 clinical trials were completed, i.e. on average, 7.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Affiliated Hospital of Guilin Medical University" #1 sponsor was "Asahi Kasei Pharma Corporation" with 2 trials, followed by "BeiGene" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Akeso" with 1 trials sponsored and "Beijing Shenogen Biomedical Co., Ltd" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Affiliated Hospital of Guilin Medical University" #1 collaborator was "First People's Hospital of Foshan" with 2 trials as a collaborator, "Guilin Medical University, China" with 2 trials as a collaborator, "Jiangsu Suzhong Pharmaceutical Group Co., Ltd." with 2 trials as a collaborator, "Affiliated Cancer Hospital & Institute of Guangzhou Medical University" with 1 trials as a collaborator and "Anhui Provincial Hospital" with 1 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Affiliated Hospital of Guilin Medical University" are "Nasopharyngeal Carcinoma" (2 trials), "Acute Ischemic Stroke" (1 trials), "Advanced HBV-Related Hepatocellular Carcinoma (HCC)" (1 trials), "Alzheimer's Disease" (1 trials) and "Chronic Kidney Disease" (1 trials). Many other conditions were trialed in "Affiliated Hospital of Guilin Medical University" in a lesser frequency.

Most popular intervention types in "Affiliated Hospital of Guilin Medical University" are "Drug" (18 trials), "Biological" (1 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide (CTX)" (2 trials), "Mizoribine (MZR)" (2 trials), "Placebo" (2 trials), "ATM-AVI" (1 trials) and "Abelmoschus manihot" (1 trials). Other intervention names were less common.

The vast majority of trials in "Affiliated Hospital of Guilin Medical University" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Affiliated Hospital of Guilin Medical University". 1 are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Affiliated Hospital of Guilin Medical University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Affiliated Hospital of Guilin Medical University, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".